TP53 and hepatocellular carcinoma: Interestingly, the treatment with ACV-TP-T in cell lines where p53 is mutated or missing (HuH7 and Hep3B, respectively), mimicking HCC cells in which the p53 pathway is often lacking due to frequent mutations [39], was consistently able to induce cellular arrest.